Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Almoosa Health Company (4018.SR)
SAR118.00
-1.70 (-1.42%)
SA SAU Healthcare Medical - Care Facilities
Address
3256 Dhahran Road 31982
Al Mubarraz, SA
Al Mubarraz, SA
CEO
Malek Abdulaziz Abdullah Al Moosa
Website
almoosahealthgroup.org
IPO
2025-01-07
ISIN SA1661VHUP11
Description
Almoosa Health Company functions as a private healthcare provider situated in Saudi Arabia. The firm engages in storing medical goods and distributing pharmaceuticals, beauty products, and single-use medical supplies. Additionally, it oversees the operation of hospitals and pharmacies, offering a comprehensive suite of services that includes critical care, active rehabilitation, extended care, in-home healthcare assistance, and health-related educational programs. Founded in 1996, the company is headquartered in Al Mubarraz, Saudi Arabia, and operates as a subsidiary of Abdulaziz bin Abdullah Almoosa Investment Company.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
SAR118.00
-1.70 (-1.42%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
50.7K
Beta
0.35
Float Shares
13.29M
Free Float %
30.0%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.62% | -7.25% | -15.09% | -19.85% | -31.24% | -30.73% | -25.91% | -16.78% | -16.78% | -16.78% | -16.78% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
118.00
Ratings Trend (MoM)
25% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 0 | 0 |
| Hold | 3 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
2.69
Grey zone
Piotroski F-Score
5 / 9
Average
MOAT Score
3 / 10
No MOAT
Composite Rating
A-
Overall Score
4 / 5
High
DCF Score
5 / 5
High
ROE Score
4 / 5
High
ROA Score
5 / 5
High
D/E Score
2 / 5
Medium
P/E Score
2 / 5
Medium
P/Book Score
2 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Care Facilities: +10.2%+17.8% ★ Q1'26: +7.8% (vs Q1'25)
-
EPS growth Medical - Care Facilities: +19.2%+113.2% ★ Q1'26: -54.7% (vs Q1'25)
-
FCF margin FCF growth · Medical - Care Facilities: +32.0%+1.4% Q1'26: -17.2% (vs Q1'25)
-
EBIT margin Medical - Care Facilities: +11.3%+14.3% ★ Q1'26: +10.1% (vs Q1'25)
-
ROIC Medical - Care Facilities: +6.8%+7.5% ★ Q1'26: +6.9% (vs Q1'25)
-
Share dilution Medical - Care Facilities: +0.0%-0.4% ★ Q1'26: +1.5% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×3.98× Q1'26: 0.00× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 3 Rev. Ana. 3 EPS Ana. |
Dec 2027 3 Rev. Ana. 3 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
Dec 2029 2 Rev. Ana. 1 EPS Ana. |
Dec 2030 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|
| Revenue |
1.20B
est: 1.28B (-5.8%)
|
1.42B
est: 1.42B (-0.2%)
|
1.67B
1.64B – 1.69B
+17.5% YoY
|
2.09B
1.94B – 2.19B
+25.2% YoY
|
2.89B
2.75B – 2.98B
+38.1% YoY
|
3.53B
3.36B – 3.65B
+22.4% YoY
|
3.74B
3.56B – 3.86B
+5.8% YoY
|
| EBITDA |
267.22M
est: 222.15M (+20.3%)
|
203.10M
est: 247.09M (-17.8%)
|
290.27M
284.85M – 294.01M
+17.5% YoY
|
363.47M
337.21M – 381.27M
+25.2% YoY
|
502.07M
477.76M – 518.60M
+38.1% YoY
|
614.32M
584.57M – 634.54M
+22.4% YoY
|
650.17M
618.69M – 671.57M
+5.8% YoY
|
| EBIT |
183.90M
est: 158.62M (+15.9%)
|
203.10M
est: 176.43M (+15.1%)
|
207.26M
203.39M – 209.93M
+17.5% YoY
|
259.54M
240.78M – 272.24M
+25.2% YoY
|
358.50M
341.14M – 370.30M
+38.1% YoY
|
438.65M
417.41M – 453.09M
+22.4% YoY
|
464.25M
441.77M – 479.53M
+5.8% YoY
|
| Net Income |
94.42M
est: 80.34M (+17.5%)
|
200.40M
est: 214.75M (-6.7%)
|
252.49M
224.81M – 274.10M
+17.6% YoY
|
270.58M
239.44M – 288.24M
+7.2% YoY
|
346.07M
324.28M – 360.87M
+27.9% YoY
|
467.89M
438.44M – 487.91M
+35.2% YoY
|
557.94M
522.82M – 581.81M
+19.2% YoY
|
| SGA |
190.54M
est: 225.24M (-15.4%)
|
245.50M
est: 250.53M (-2.0%)
|
294.30M
288.81M – 298.09M
+17.5% YoY
|
368.53M
341.89M – 386.57M
+25.2% YoY
|
509.05M
484.40M – 525.81M
+38.1% YoY
|
622.86M
592.70M – 643.36M
+22.4% YoY
|
659.21M
627.29M – 680.90M
+5.8% YoY
|
| EPS |
2.13
est: 1.82 (+17.0%)
|
4.54
est: 4.87 (-6.7%)
|
5.72
5.09 – 6.21
+17.6% YoY
|
6.13
5.42 – 6.53
+7.2% YoY
|
7.84
7.35 – 8.18
+27.9% YoY
|
10.60
9.93 – 11.05
+35.2% YoY
|
12.64
11.84 – 13.18
+19.2% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-11 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-10 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-07 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-06 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-05 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-04 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-03 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-30 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-29 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-28 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-27 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-26 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-23 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-22 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-21 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-20 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-19 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-16 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
33.02M
OE per share TTM
0.75
Owner's Yield
0.60%
Maintenance CapEx ratio
35.23%
Maint CapEx / Avg PPE
166.0%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
Held by 23 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | iShares MSCI Saudi Arabia ETF KSA | 0.14% | 891.9K | 0.75% |
| 2 | iShares MSCI Emerging Markets Small-Cap ETF EEMS | 0.02% | 80.6K | 0.72% |
| 3 | iShares MSCI EM Small Cap UCITS ETF IEMS.L | 0.02% | 68.3K | 0.74% |
| 4 | State Street SPDR MSCI Emerging Markets Small Cap UCITS ETF EMSD.L | 0.02% | 108.4K | 0.55% |
| 5 | Vanguard FTSE All-World ex-US Small-Cap ETF VSS | 0.01% | 1.54M | 0.06% |
| 6 | State Street SPDR Morningstar Multi-Asset Global Infrastructure UCITS ETF (Dist) MAGI.L | 0.01% | 60.5K | 0.40% |
| 7 | Vanguard FTSE Emerging Markets Shares ETF VGE.AX | 0.00% | 51.9K | 0.48% |
| 8 | Vanguard FTSE Emerging Markets All Cap Index ETF VEE.TO | 0.00% | 117.0K | 0.26% |
| 9 | iShares Core MSCI EM IMI UCITS ETF EIMI.L | 0.00% | 1.50M | 0.18% |
| 10 | iShares Core MSCI EM IMI UCITS ETF EIMU.L | 0.00% | 61.6K | 0.18% |
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
70.4K
Shares Outstanding
44.30M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Sara Abdulaziz Abdullah Al Moosa | Head of Marketing & Community Partnership and Executive Director | 133.0K | female |
| Malek Abdulaziz Abdullah Al Moosa | MD, Chief Executive Officer & Executive Director | 133.0K | male |
| Zainab Abdulaziz Abdullah AlMoosa | CEO of Almoosa Specialist Hospital & Vice Chairman | 133.0K | — |
| Mahmoud Mustafa Mohamed Abdulkarim | Head of Quality & Chief of Patient Safety Department | — | — |
| Mamdouh Al Nahwi | Chief Medical Officer | — | — |
| Abdul Rahim Muhammed Basim Alnatour | Head of Engineering Services Department | — | — |
| Mona Ali Khamis | CEO of Almoosa Rehabilitation Hospital | — | — |
| Naief Alkhowaiter | Head of Operations Department | — | male |
| Shailesh Chander | Head of Finance Department | — | male |
| Mohammad Afzal | Chief Audit Executive | — | — |
| Abdullah Muhanna Al Hubail | Legal & Compliance Director and Board Secretary | — | male |
| Hera Hacob Tashjian | Head of Nursing | — | female |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 4018.SR
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
